ScreenIn3D reports on how their proprietary lab-on-a-chip technology is enabling cancer researchers to miniaturize their testing of biopsy tissue samples across a wide range of modalities and to test both single and combination drug therapies on live tissue samples.
Polpharma Biologics, an international biotech company focused on developing and manufacturing biosimilars, has received approval from the European Commission for Tyruko (natalizumab) as the first and only biosimilar for relapsing forms of multiple sclerosis (MS) in Europe. Tyruko was developed by Polpharma Biologics and will be commercialized by its collaboration partner Sandoz.
Revvity has expanded its imaging portfolio with the introduction of three new imaging systems – the IVIS platform, the Quantum GX3 microCT, and the Vega ultrasound system.
Shimadzu has released the AIMsight infrared microscope. AIMsight builds on the high sensitivity of Shimadzu’s well-known AIM-9000 to offer an improved operational experience through greater automation. AIMsight is intended for industrial applications, such as drug manufacturing.
The COMBO-ONE Viscometer/DRI detector from TESTA Analytical sets a new standard for demanding GPC/SEC applications, such as those focused on investigating the structure and branching of polymers.
INTEGRA Biosciences has launched MIRO CANVAS, a compact digital microfluidics platform for fully automated next generation sequencing (NGS) sample preparation. The revolutionary system significantly simplifies NGS workflows for more walk-away time and higher lab productivity.
The Micro Flow Meter from Biotech Fluidics is a new device designed to continuously monitor ultra-low fluidic flows in real-time.
The pathology laboratory has been fitted out with industry gold standard equipment including ground-breaking technology in the diagnosis of cancer conditions which will enable a far greater volume of accurate tests to be processed, around the clock, seven days a week.
Investment to expand cell line development capabilities and accelerate customer workflows, as part of its diverse and tailored antibody solutions
Cambrex announced the completion of its $38 million capacity expansion at its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. This expansion doubles the facility’s manufacturing capacity, with new state-of-the-art analytical and chemical development laboratories, two new clinical manufacturing suites, and a small-scale commercial manufacturing operation with three work centers […]
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.